Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial - Concepedia

Concepedia

Publication | Closed Access

Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial

63

Citations

20

References

2021

Year

Taku Kobayashi, Satoshi Motoya, Shirô Nakamura, Takayuki Yamamoto, Masakazu Nagahori, Shinji Tanaka, Tadakazu Hisamatsu, Fumihito Hirai, Hiroshi Nakase, Kenji Watanabe,

The Lancet. Gastroenterology & hepatology

InflammationAnti-inflammatoryAllergyGastroenterologyUlcerative ColitisMedicineInflammatory Disease

References

	Year	Citations

Page 1